4//SEC Filing
Graboyes Marc H 4
Accession 0001127602-10-011098
CIK 0001097264other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 5:07 PM ET
Size
9.4 KB
Accession
0001127602-10-011098
Insider Transaction Report
Form 4
Graboyes Marc H
VP, General Counsel
Transactions
- Sale
Common Stock
2010-04-12$8.58/sh−75,000$643,530→ 57,912 total - Exercise/Conversion
Common Stock
2010-04-12$2.70/sh+75,000$202,500→ 132,912 total - Exercise/Conversion
Stock Options (Right to Buy)
2010-04-12−75,000→ 0 totalExercise: $2.70From: 2007-02-10Exp: 2016-02-10→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 plan under which Mr. Graboyes sold a portion of his holdings for tax and estate planning purposes.
- [F2]The price represents the weighted average sale price for multiple transactions reported on this line. The prices of the transactions ranged from $8.53 to $8.60. Upon request of the SEC staff, Allos Therapeutics, Inc. (the "Company") or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold at each separate price.
- [F3]Stock options vest according to the following schedule: One fourth (1/4) of the total number of shares subject to this option shall vest 12 months after the date of grant and an additional one forty-eighths (1/48) of the total number of shares subject to the option shall vest each one month period thereafter, until all such shares are vested and exercisable.
Documents
Issuer
ALLOS THERAPEUTICS INC
CIK 0001097264
Entity typeother
Related Parties
1- filerCIK 0001305811
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 5:07 PM ET
- Size
- 9.4 KB